Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group

Catherine Reenaers, Guy Lambrecht, Lieven Pouillon, Filip Baert, Anneline Cremer, Arnaud Colard, Christophe Claessens, Thomas Billiet, Jeroen Geldof, Astrid De Zutter, Jean-François Rahier, Michael Somers, Dries Reynders, Laura Vansteenkiste, Ingrid Arijs, Edouard Louis, Unknown, Bram Verstockt

Open source

DOI: 10.1093/ecco-jcc/jjag100
Published: 2026-08
Container: Journal of Crohn's and Colitis
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ecco-jcc/jjag100,
  title = {Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group},
  author = {Catherine Reenaers and Guy Lambrecht and Lieven Pouillon and Filip Baert and Anneline Cremer and Arnaud Colard and Christophe Claessens and Thomas Billiet and Jeroen Geldof and Astrid De Zutter and Jean-François Rahier and Michael Somers and Dries Reynders and Laura Vansteenkiste and Ingrid Arijs and Edouard Louis and Unknown and Bram Verstockt},
  year = {2026},
  journal = {Journal of Crohn's and Colitis},
  doi = {10.1093/ecco-jcc/jjag100},
  url = {https://doi.org/10.1093/ecco-jcc/jjag100}
}

RIS

TY  - JOUR
TI  - Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group
AU  - Catherine Reenaers
AU  - Guy Lambrecht
AU  - Lieven Pouillon
AU  - Filip Baert
AU  - Anneline Cremer
AU  - Arnaud Colard
AU  - Christophe Claessens
AU  - Thomas Billiet
AU  - Jeroen Geldof
AU  - Astrid De Zutter
AU  - Jean-François Rahier
AU  - Michael Somers
AU  - Dries Reynders
AU  - Laura Vansteenkiste
AU  - Ingrid Arijs
AU  - Edouard Louis
AU  - Unknown
AU  - Bram Verstockt
PY  - 2026
JO  - Journal of Crohn's and Colitis
DO  - 10.1093/ecco-jcc/jjag100
UR  - https://doi.org/10.1093/ecco-jcc/jjag100
ER  -

APA

Reenaers, C., Lambrecht, G., Pouillon, L., Baert, F., Cremer, A., Colard, A., Claessens, C., Billiet, T., Geldof, J., Zutter, A. D., Rahier, J., Somers, M., Reynders, D., Vansteenkiste, L., Arijs, I., Louis, E., Unknown, & Verstockt, B. (2026). Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjag100

Source records

crossref · retrieved 2026-11-08T17:51:01.587Z